A tiny shock to the spine: a new hope for diabetic foot pain?

NCT ID NCT07740707

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a short, 14-day spinal cord stimulation procedure can reduce severe nerve pain in the feet of people with diabetes who haven't found relief from standard treatments. Half of the 88 participants will receive the stimulation plus usual diabetic foot care, while the other half will receive only usual care. The study tracks pain levels, sleep quality, and quality of life over six months to see if this minimally invasive approach offers a meaningful benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
short-term spinal cord stimulation (a minimally invasive procedure)
What this could lead to
If it works, this could offer a new, minimally invasive option for people with diabetic foot pain that hasn't responded to standard treatments, potentially easing pain and improving sleep and daily life.
What could go wrong
This is a relatively small, single-center trial, and the procedure is invasive, carrying risks like infection or nerve damage. The pain relief may not last beyond the 6-month follow-up, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY DIABETIC FOOT NEUROPATHIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.